Nahdi Medical Company

TADAWUL:4164.SR

119.6 (SAR) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 182.188260.607232.95182.602222.6276.702262.342138.56264.869287.114247.382150.74259.214240.388206.926166.80693.097270.643294.606
Depreciation & Amortization 175.126175.133161.976158.972152.58149.201157.328149.532157.198145.265144.647151.235137.665145.269137.33199.738134.561129.231129.231
Deferred Income Tax 0000000000000000000
Stock Based Compensation 0000000000000000000
Change In Working Capital 201.103-301.65956.952-149.72189.537-372.911178.063183.075-177.354-107.459154.22986.289-107.825-133.178141.312395.413290.571-309.368-309.368
Accounts Receivables 29.599-75.131-43.504-34.52102.695-92.462-13.86978.613-53.41-12.48-5.8340.5564.696-23.578-69.327108.547-2.261-23.822-23.822
Change In Inventory 59.42849.125-352.092-86.9184.471-8.281-203.90177.4324.841-4.507-204.7882.256-23.35388.602-61.653102.06473.222-182.356-182.356
Change In Accounts Payables 37.587-195.391505.47110.966-0.647-236.218483.041-15.00453.4112.48494.062-7.952-109.301-182.816343.8060000
Other Working Capital 74.489-80.262-52.923-39.2573.018-35.949-87.20742.035-182.195-102.953359.0094.033-84.471-221.78202.965184.802219.61-103.19-103.19
Other Non Cash Items 1.26346.094224.62826.881-14.393-66.03914.98325.97929.22612.25113.356-34.86616.075-79.63617.033-22.015-112.383179.524155.561
Operating Cash Flow 559.68107.089462.428218.734550.324-13.046612.717497.146273.939337.172559.614353.398305.129172.842502.602639.942405.846270.03270.03
Investing Activities:
Investments In Property Plant And Equipment -76.229-90.467-100.82-128.406-105.681-75.079-75.344-75.837-78.251-56.35-64.795-77.165-79.544-52.843-96.915-55.438-78.27-81.07-81.07
Acquisitions Net 0.0331.1420.2540.1210.133000.103000.0354.4782.5450.07900000
Purchases Of Investments 000000000000600200-8000000
Sales Maturities Of Investments 0000000000000000000
Other Investing Activites 0-11.614-9.851-8.098-9.249-5.911-7.137-4.14-0.005-0.030.035-1.863598.953187.284-801.1656.929297.415-55.821-55.821
Investing Cash Flow -76.196-89.324-100.566-128.285-105.548-75.079-75.344-75.734-78.256-56.38-64.76-72.687523.001147.236-896.915-48.509219.145-136.891-136.891
Financing Activities:
Debt Repayment 000000000000000-85.146-65.56600
Common Stock Issued 0000000000000000000
Common Stock Repurchased 0000000000000000000
Dividends Paid -325-1.109-388.8910-325-39000-300.300-200-600-4600-2000-167.5-167.5
Other Financing Activities -139.242-58.234-113.471-96.407-89.124-150.557-99.586-106.37-95.986-104.526-110.082-127.008-104.554-74.366-76.13900-80.407-80.407
Financing Cash Flow -464.242-59.343-502.362-96.407-414.124-540.557-99.586-106.37-396.286-104.526-110.082-327.008-704.554-534.366-76.139-285.146-65.566-247.907-247.907
Other Information:
Effect Of Forex Changes On Cash 0.0040.0420.777-0.8280.002-0.0180.396-0.003-0.001-0-0.206-0.0010.003-0.02600000
Net Change In Cash 19.247-41.536-139.723-6.78530.654-628.7438.182315.04-200.603176.265384.565-46.298123.579-214.314-470.452306.287559.425-114.768-114.768
Cash At End Of Period 747.65728.404769.94909.662916.447885.7941,514.4941,076.312761.272961.875785.61401.044447.343323.764538.0781,008.53702.243-114.768-114.768